1
|
Mohlenhoff BS, Insel PS, Mackin RS, Neylan TC, Flenniken D, Nosheny R, Richards A, Maruff P, Weiner MW. Total Sleep Time Interacts With Age to Predict Cognitive Performance Among Adults. J Clin Sleep Med 2018; 14:1587-1594. [PMID: 30176964 DOI: 10.5664/jcsm.7342] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2018] [Accepted: 06/18/2018] [Indexed: 11/13/2022]
Abstract
STUDY OBJECTIVES To investigate interactions between high and low amounts of sleep and other predictors of cognitive performance. METHODS We used four cognitive tests to determine whether sleep time interacted with age, personal history of a memory problem, parental history of a memory problem, or personal concerns about memory and were associated with cognitive performance. Data were collected from an internet-based cohort study. We used an ordinary least squares regression with restricted cubic splines, controlling for demographic variables and comorbidities. RESULTS We found significant nonlinear interactions between (1) total sleep time and age and (2) total sleep time and personal history of a memory problem and cognitive performance. Short and long sleep durations and self-reported memory complaints were associated with poorer performance on a test of attention and this was true to a greater degree in younger and older adults. A repeat analysis excluding subjects reporting dementia was significant only for the test of attention. CONCLUSIONS These results extend existing data on sleep duration and cognition across the lifespan by combining in a single study the results from four specific cognitive tests, both younger and older adults, and four self-reported risk factors for cognitive impairment. Longitudinal studies with biomarkers should be undertaken to determine whether causal mechanisms, such as inflammation or amyloid buildup, account for these associations.
Collapse
Affiliation(s)
- Brian S Mohlenhoff
- Department of Psychiatry, University of California, San Francisco, San Francisco, California.,Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,Mental Health Service, Department of Veterans Affairs Medical Center, San Francisco, California
| | - Philip S Insel
- Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.,San Francisco Veterans Affairs Medical Center, Veterans Health Research Institute (NCIRE), San Francisco, California
| | - R Scott Mackin
- Department of Psychiatry, University of California, San Francisco, San Francisco, California.,Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,San Francisco Veterans Affairs Medical Center, Veterans Health Research Institute (NCIRE), San Francisco, California
| | - Thomas C Neylan
- Department of Psychiatry, University of California, San Francisco, San Francisco, California.,Mental Health Service, Department of Veterans Affairs Medical Center, San Francisco, California
| | - Derek Flenniken
- Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,San Francisco Veterans Affairs Medical Center, Veterans Health Research Institute (NCIRE), San Francisco, California
| | - Rachel Nosheny
- Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,San Francisco Veterans Affairs Medical Center, Veterans Health Research Institute (NCIRE), San Francisco, California
| | - Anne Richards
- Department of Psychiatry, University of California, San Francisco, San Francisco, California.,Mental Health Service, Department of Veterans Affairs Medical Center, San Francisco, California
| | - Paul Maruff
- Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.,Cogstate, Ltd., Melbourne, Victoria, Australia
| | - Michael W Weiner
- Department of Psychiatry, University of California, San Francisco, San Francisco, California.,Center for Imaging of Neurodegenerative Diseases (CIND), San Francisco, California.,Mental Health Service, Department of Veterans Affairs Medical Center, San Francisco, California.,Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California
| |
Collapse
|
2
|
Brébion G, Smith MJ, Widlocher D. Discrimination and response bias in memory: effects of depression severity and psychomotor retardation. Psychiatry Res 1997; 70:95-103. [PMID: 9194203 DOI: 10.1016/s0165-1781(97)03098-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Although memory disorders have been well documented in depression, there is controversy concerning depressives' performance on recognition memory tasks; e.g. whether they have impaired discrimination and conservative or liberal response bias according to signal detection theory. In addition, symptomatic correlates of discrimination and response bias indices have been lacking. A word recognition memory task analyzed according to the two high threshold theory was administered to 26 depressives and 26 controls. Depressives obtained a lower index of discrimination (Pr) than controls. The index of response bias (Br) was not different between groups. In the depressed group, overall severity of depression was related to discrimination, whereas psychomotor retardation level was related to response bias. Cognitive performance of depressives could be advantageously analyzed in terms of these two dimensions of symptomatology.
Collapse
Affiliation(s)
- G Brébion
- New York State Psychiatric Institute, New York 10032, USA
| | | | | |
Collapse
|
3
|
Neri M, Andermarcher E, De Vreese LP, Rubichi S, Sacchet C, Cipolli C. Transient global amnesia: memory and metamemory. AGING (MILAN, ITALY) 1995; 7:423-9. [PMID: 8835079 DOI: 10.1007/bf03324356] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Twenty patients (mean age 64 years) with a previous episode of transient global amnesia (TGA) were examined to assess the functioning of objective memory (by using the Randt Memory Test), the metamemory capacities (Sehulster Memory Scale), the residual level of retrograde amnesia (Questionnaire of Remote Events), and the level of depression (Geriatric Depression Scale). Patients with residual retrograde amnesia scored significantly lower than non-amnesic ones on indices of both short-term and long-term memory, and for one of three main metamemory components, namely self-rating of memory functioning through comparison with memory functioning of peers (Set3). Age, time interval from TGA attack and TGA duration did not prove to influence memory and metamemory scores. Retrograde amnesia and depression were rather substantially associated (1/5), and this association was found to negatively influence nearly all memory and metamemory scores. Depression level showed a positive correlation with short-term memory functioning in non-amnesics. The different pattern and strength of the relationships between metamemory components and objective memory dimensions observed in amnesics and non-amnesics indicate that metamemory evaluations are more closely related to memory functioning in amnesics than in non-amnesics.
Collapse
Affiliation(s)
- M Neri
- Department of Internal Medicine, University of Modena, Italy
| | | | | | | | | | | |
Collapse
|
4
|
Neri M, Andermarcher E, Pradelli JM, Salvioli G. Influence of a double blind pharmacological trial on two domains of well-being in subjects with age associated memory impairment. Arch Gerontol Geriatr 1995; 21:241-52. [PMID: 15374200 DOI: 10.1016/0167-4943(95)00659-9] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/1994] [Revised: 05/29/1995] [Accepted: 06/06/1995] [Indexed: 11/26/2022]
Abstract
This random double-blind trial compares psychological well-being and perceived quality of life in 60 subjects (18 M, 42 F), mean age 61 years, with age-associated memory impairment (AAMI), who were administered a standardised ginseng-containing vitamin complex or placebo for 9 months. We evaluated psychological well-being, in terms of affective status and memory functioning using the Symptom Rating Test [SRT] (depression, anxiety, somatisation, inadequacy) and Randt Memory Test [RMT] (memory index [MI]), respectively, and the quality of life, using the Life Satisfaction in the Elderly Scale [LSES]. At final evaluation, SRT did not differ in the drug and placebo groups, whereas MI and LSES were significantly higher in the drug-treated group. Moreover, the negative correlation between the affective (SRT) and cognitive (MI) component of psychological well-being waned in the drug-treated but not placebo group. In the drug-treated group, a positive correlation emerged between the cognitive index and social contacts, mood and self-concept factors of the LSES. In both groups, the initial negative correlations between quality of life (LSES) and affection (SRT) persisted at the end of the study. Drug-treated AAMI subjects differ from controls in part by improved scores on objective cognitive tests but even more so by modifications of the correlations among indexes of psychological well-being and quality of life.
Collapse
Affiliation(s)
- M Neri
- Department of Internal Medicine, Chair of Geriatrics and Gerontology, University of Modena, Ospedale Estense, Viale Vittorio Veneto, 9, 1-41100 Modena, Italy.
| | | | | | | |
Collapse
|